Two Sigma Investments, LP Adial Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.21 - $0.37 $17 - $31	-84 Reduced 0.47%	17,623 $3,000
Q1 2023 May 15, 2023	SELL	$0.24 - $0.56 $9,763 - $22,781	-40,682 Reduced 69.67%	17,707 $6,000
Q3 2022 Nov 14, 2022	BUY	$0.03 - $46.0 $1,751 - $2.69 Million	58,389 New	58,389 $20,000
Q2 2019 Aug 14, 2019	SELL	N/A	-25,472 Closed	0 $0
Q1 2019 May 15, 2019	BUY	N/A	13,697 Added 116.32%	25,472 $87,000
Q4 2018 Feb 14, 2019	BUY	N/A	11,775 New	11,775 $60,000

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $26M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.